H.C. Wainwright analyst Patrick Trucchio reiterated a Buy rating on Mind Medicine (MNMD – Research Report) today and set a price target of ...

In a report released today, Luca Issi from RBC Capital maintained a Buy rating on Arrowhead Pharmaceuticals (ARWR – Research Report), with a ...

The shares were sold at a price of $21 each, totaling $20,139. Following this transaction, Olukotun holds 35,781 shares ...

A new study led by Western researchers found frequent treatment with intranasal oxytocin – a hormone in the brain associated ...

You could say that Taylor Swift’s championship era is in its second consecutive season. The 14-time Grammy Award-winning ...

Buffalo Bills cornerback Christian Benford was ruled out of the AFC title game against the Kansas City Chiefs on Sunday night with a concussion. Benford was carted from the ...

HC Wainwright reaffirmed their buy rating on shares of Arrowhead Pharmaceuticals (NASDAQ:ARWR – Free Report) in a research ...

Stock analysts at Leerink Partnrs reduced their Q3 2025 earnings per share estimates for Arrowhead Pharmaceuticals in a ...

Arrowhead Pharmaceuticals Inc (ARWR) stock saw a decline, ending the day at $20.76 which represents a decrease of $-0.77 or -3.58% from the prior close of $21.53. The stock opened at $21.23 and ...

Arrowhead Pharmaceuticals Inc (ARWR) stock saw a modest uptick, ending the day at $21.53 which represents a slight increase of $1.82 or 9.23% from the prior close of $19.71. The stock opened at $20.05 ...

Guidewire Software (GWRE) saw its shares surge in the last session with trading volume being higher than average. The latest ...

Commenting on the submission, Chris Anzalone, PhD, President and CEO at Arrowhead, said, “With the plozasiran NDA submission and FDA’s acceptance for filing complete, we are laser focused on our ...